Imunon Inc.
IMNN | NASDAQ
$1.56
+$0.13 (+9.09%)
Sep 22, 2026, 10:46 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 500K | 500K | 500K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | 500K | 500K | 500K |
Operating Income | -14.65M | -19.13M | -21.03M | -24.92M | -21.01M | -18.49M |
Interest Income | 155.67K | 450.22K | 725.82K | 502.58K | 18.15K | 66.55K |
Pretax Income | -14.5M | -18.62M | -20.8M | -37.47M | -22.15M | -23.33M |
Net Income | -14.5M | -18.62M | -19.51M | -35.9M | -20.77M | -21.48M |
Selling & General & Admin | 6.87M | 7.49M | 9.74M | 13.69M | 10.89M | 7.64M |
Research & Development | 7.78M | 11.64M | 11.29M | 11.73M | 10.62M | 11.34M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 14.65M | 19.13M | 21.03M | 25.42M | 21.51M | 18.99M |
Interest Expense | n/a | n/a | 197.08K | 5.03M | 569.88K | 1.29M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.65M | 19.13M | 21.03M | 25.42M | 21.51M | 18.99M |
Income Tax Expense | n/a | n/a | -1.28M | -1.57M | -1.38M | -1.85M |
Shares Outstanding (Basic) | 2.12M | 882.29K | 693.47K | 547.63K | 27.74K | 163.36K |
Shares Outstanding (Diluted) | 2.12M | 882.29K | 693.47K | 547.63K | 27.74K | 163.36K |
EPS (Basic) | -6.83 | -21.10 | -28.14 | -65.55 | -748.77 | -131.51 |
EPS (Diluted) | -6.83 | -21.10 | -28.14 | -65.55 | -748.77 | -131.51 |
EBITDA | -13.8M | -17.9M | -19.88M | -31.71M | -20.88M | -21.3M |
EBIT | -14.5M | -18.62M | -20.6M | -32.44M | -21.58M | -22.04M |
Depreciation & Amortization | 698.9K | 718.12K | 720.01K | 731.63K | 702.92K | 741.52K |
Add to Watchlist
Select watchlists to add or remove IMNN